| Virginia Polytechnic Inst. & State Univ.; Blacksburg, VA | B.S | 1969-72 | Biology |
| University of Kentucky; Lexington, KY | M.S. | 1978-80 | Microbiology (Immunology) |
| University of Kentucky; Lexington, KY | Ph D. | 1980-83 | Microbiology (Immunology) |
| Scripps Clinic & Research Institute; La Jolla. CA | Postdoc fellow | 1983-87 | Immunology |
Professional Experience:
Research Biologist; 1974-1978; Immunology Division Department of Experimental
Hematology, Armed Forces Radiobiology Research Institute; Bethesda, MD
Graduate Teaching Assistant; 1978- 1980 and Spring, 1982; Department of Microbiology, Thomas Hunt Morgan School of Biological Sciences; University of Kentucky; Lexington, KY
Graduate Research Assistant; 1979-1983; Department of Medical Microbiology and Immunology and Department of Pathology; University of Kentucky Medical Center; Lexington, KY
Postdoctoral Research Fellow; 1983-1987; Department of Immunology; Scripps Clinic and Research Institute; La Jolla, CA (In the laboratories of Drs. Michael J. Bevan and Linda A. Sherman)
Assistant Professor of Microbiology and Immunology; 1987-1994; West Virginia University School of Medicine; Morgantown, WV
Associate Professor of Microbiology and Immunology; 1994-present; West Virginia University School of Medicine, Morgantown, WV
Awards, Honors, and Professional Activities:
Damon Runyon-Walter Winchell Cancer Fund Fellow, 1984-86; NIH Postdoctoral
Fellowship (awarded July, 1984declined); Sigma Xi Scientific Research Society
(since July, 1982); Isabelle Kircher Graduate Research Fellow, University of
Kentucky (1982-83); Who's Who in American Colleges & Universities (1971-72).
Chair & Organizer for 23rd Annual Mid-Atlantic Immunobiologists Conference; Harpers Ferry, WV.
Invited member NIAID/NIH Special Review Group on "Immunologic Enhancement of Vaccine Immunogenicity" (June, 1994); Grant reviewer for NSF, North Carolina Biotechnology Center, and Arkansas Biotechnology Consortium; Reviewer for Journal of Immunology and Journal of Leukocyte Biology; Member of American Association of Immunologists (AAI), Amer. Assoc. for the Advancement of Science (AAAS) and Sigma Xi Scientific Research Society.
Publications:
Sun, R., S. E. Shepherd, S. S. Geier, C. T. Thompson, J. M. Sheil, and S. G. Nathenson. 1995. Evidence that the antigen receptor of cytotoxic T Iymphocytes interact with a common recognition pattern on the H-2Kb molecule.
Immunity. 3:573-582.
Schafer, R. and J. M. Sheil. 1995. Superantigens. Adv. In Pediatric Infect. Diseases 10: 369-390.
Sheil, J. M., T. D. Schell, S. E. Shepherd, G. F. Klimo, J. M. Kioschos, and Y. Paterson. 1994. Presentation of a horse cytochrome c peptide by multiple H-2b class I MHC molecules to B6- and bml-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer peptide-specific CTL recognition. Eur. J. Immunol. 24: 2141-2149.
Yun, T. J., M. D. Taliquist, E. M. Rohren, J. M. Sheil, and L. R. Pease. 1994. Alloantigenicity and peptide presentation is influenced by changing shallow pocket B of the H-2Kb molecule. Int. Immunol. 6: 1037-1047.
Shepherd, S. E., R. Sun, S. G. Nathenson, and J. M. Sheil. 1992. Selective reactivity of CD8-independent T Iymphocytes to a cytotoxic T Iymphocyte-selected H-2Kb mutant altered at position 222 in the a3 domain. Eur. J. Immunol. 22: 647-653.
Sheil, J. M., S. E. Shepherd, G. F. Klimo, and Y. Paterson. 1992. Identification of an autologous insulin B chain peptide as the target antigen of H-2Kb-restricted cytotoxic T Iymphocytes. J. Exp. Med. 175: 545-552.
Nathenson, S. G., K. Kesari, J. M. Sheil, and P. Ajitkamar. 1989. Use of mutants to analyze regions on the H-2Kb molecule for interaction with immune receptors. Cold Spring Harbor Symp. Quant. Biol. 54: 521-528.